Table 1.
Descriptive Summary of HPV Survey Studies (n=672)
| HNSCC |
CrCa |
PeCa |
CxCa |
|||||
|---|---|---|---|---|---|---|---|---|
| HPV16+ | Total | HPV16+ | Total | HPV16+ | Total | HPV16+ | Total | |
| Total (%) | 2 (1.3) | 156 (23.7) | 3 (4.5) | 66 (10) | 6 (54) | 11 | 65 (14.9) | 436 (66.2) |
| Men (%) | 2 (1.6) | 121 (77.6) | 2 (66.7) | 38 (57.6) | 6 () | 11 | 0 | 0 |
| Women (%) | 0 | 35 (22.4) | 1 (33.3) | 28 (42.4) | 0 | 0 | 65 (14.9) | 436 (100) |
| Mean age±SD | 65.5±12.6 | 60.5±12.6 | 64.3±13.2 | 59.3±14.4 | 35.0±5.5 | 35.8±5.7 | 38.4±13.6 | 35.3±10.1 |
| Range | 54-77 | 28-86 | 50-76 | 27-85 | 28-40 | 26-44 | 23-62 | 18-73 |
| Other HPVsa | - | - | - | - | - | - | 25 (38.5) | 198 (45.4) |
a
Co-infected with other HPVs. HNSCC, head and neck squamous cell carcinoma; CrCa, colorectal cancer; PeCa, penile cancer; CxCa, cervical cancer; SD, standard deviation.